The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: A comparative study

Journal of Drugs in Dermatology

Volumn 9, Issue 4, 2010, Pages 315-322

  Trelles, Mario A ^a   Velez, Mariano ^a,b   Gold, Michael H ^c  

^a Antoni de Gimbernat Foundation   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c GOLD SKIN CARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; DEXAMETHASONE; HYDROQUINONE; ISOTRETINOIN; RETINOIC ACID; TT 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBON DIOXIDE LASER; CHLOASMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MONOTHERAPY; PATIENT SATISFACTION; SCORING SYSTEM; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; LASER; MELANOSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OINTMENT; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASERS, GAS; MELANOSIS; MIDDLE AGED; OINTMENTS;

EID: 77953644010     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Newcomer VD, Lindbert MC, Stenbert TH. A melanosis of the face ("chloasma"). Arch Dermatol. 1961;83:284-297.
2. Kang WH, Yoon KH, Lee ES, et al. Melasma: Histopathological characteristics in 56 Korean patients. British J Derm. 2002;146(2):228-237. (Pubitemid 34264392)
3. Ortonne JP, Bisset DL. Latest insights into skin hyperpigmentation. J Invest Dermatol Symp Proc. 2008;13(1):10-14.
4. Kim H, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Science. 2007;46(2):111-116. (Pubitemid 46467289)
5. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048-1065. (Pubitemid 44716465)
6. Negishi K, Kushikata N, Tezuka Y et al. Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed light treatment. Dermatol Surg. 2004;30(6):881-886. (Pubitemid 38765727)
7. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and post inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592-597. (Pubitemid 24292440)
8. Stratigos AJS, Dover JS, Arndt KA. Laser treatment of pigmented lesions. How far have we gone? Arch Dermatol. 2000;136(7):915-921. (Pubitemid 30604291)
9. Railan D, Kilmer S. Treatment of benign pigmented cutaneous lesions. Cutaneous and Cosmetic Laser Surgery. Ed. Goldman MP (ed). Mosby Elservier Inc.; Philadelphia, PA. 2006:93-108.
10. 2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma. Dermatol Surg. 2003;29(1):59-64.
11. Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: A pilot study. Dermatol Surg. 2005;31(12)1645-1650. (Pubitemid 43031166)
12. Tannous ZS, Astner S. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther. 2005;7(1):39-43. (Pubitemid 40896751)
13. Goldberg DJ, Berlin AI, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med. 2008;40(2):134-138. (Pubitemid 351354769)
14. Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130(6):727-733. (Pubitemid 24182681)
15. Fitzpatrick RE, Goldman MP, Satur MN, Tope WD. Pulsed carbon dioxide laser resurfacing of photodamaged facial skin. Arch Dermatol. 1996;132(4):395-402. (Pubitemid 26113388)
16. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing: An evaluation of 500 patients. Dermatol Surg. 1998;24(3):315-320. (Pubitemid 28150890)
17. Sulivan SA, Dailey RA. Complications of laser resurfacing and their management. Ophthal Plast Reconstr Surg. 2000;16(6):417-426. (Pubitemid 32005765)
18. Li YH, Chen JZ, Wei HC, et al. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients. Dermatol Surg. 2008;34(5):693-701.
19. Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: Two case reports. J Cosmetic Laser Ther. 2008;10(3):167-173.
20. Kang WH, Yoon KH, Lee ES, et al. Melasma: Histopathological characteristics in 56 Korean patients. British J Dermatol. 2002;146(2):228-237. (Pubitemid 34264392)
21. Goldberg DJ, Berlin AI, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med. 2008;40(2):134-138. (Pubitemid 351354769)